https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-05-06 / Cancer Immunol. Immunother. 2011 Aug;60(8):1097-107
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-05-06 / Cancer Immunol. Immunother. 2011 Aug;60(8):1097-1072011-05-06 00:00:002019-02-15 08:52:38Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-05-01 / J. Immunother. 2011 May;34(4):382-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-05-01 / J. Immunother. 2011 May;34(4):382-92011-05-01 00:00:002019-02-15 08:46:42Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-25 / Clin Med Insights Oncol 2011;5:107-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-25 / Clin Med Insights Oncol 2011;5:107-152011-04-25 00:00:002019-02-15 08:40:05The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-20 / PLoS ONE 2011 Apr;6(4):e18801
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-20 / PLoS ONE 2011 Apr;6(4):e188012011-04-20 00:00:002019-02-15 08:53:13Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-06 / Arch. Virol. 2011 Aug;156(8):1335-442011-04-06 00:00:002011-04-06 00:00:00Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-06 / J. Virol. 2011 Jun;85(12):6015-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-06 / J. Virol. 2011 Jun;85(12):6015-232011-04-06 00:00:002019-02-15 09:21:40Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-05 / Mol. Ther. 2011 Aug;19(8):1558-68
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-05 / Mol. Ther. 2011 Aug;19(8):1558-682011-04-05 00:00:002019-02-15 08:40:06Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-01 / Immunotherapy 2011 Apr;3(4):569-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-01 / Immunotherapy 2011 Apr;3(4):569-762011-04-01 00:00:002019-02-15 08:45:54Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-04-01 / G Ital Dermatol Venereol 2011 Apr;146(2):103-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-04-01 / G Ital Dermatol Venereol 2011 Apr;146(2):103-132011-04-01 00:00:002019-02-15 08:48:39Dendritic cells and cutaneous T-cell lymphomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-03-29 / Oncol. Rep. 2011 Jun;25(6):1573-92011-03-29 00:00:002011-03-29 00:00:00Effect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
